060280.KQ
Curexo Inc.
KOE · Healthcare · Medical - Specialties · KR
KRW 8,150.00
−2.16%Year over year
Reported trailing growth
- Revenue
- +20.4%
- EBITDA
- +14.6%
- EBIT
- +244.2%
- EPS
- +181.4%
- Free cash flow
- +101.0%
- Operating cash flow
- +123.0%
Forward estimates
Based on analyst estimates
- Revenue
- -43.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.7%
- EBITDA
- +180.3%
- EBIT
- +29.4%
- Net income
- +131.8%
- EPS
- +131.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026